I agree that it's probably both, but the real key endpoint is protection against COVID infection. No one has tested that yet with any of the vaccine candidates.
Hopefully the phase III trails in the US and Brazil will read that out quickly. Ironically, it will be harder to assess in places where the outbreak is more under control...